Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Breast Dis. 2010 Jan 1;31(1):7–18. doi: 10.3233/BD-2009-0290

Figure 9.

Figure 9

Figure 9

(a) In a KPL4 xenograft, the mean tumor volume over time is shown for capecitabine 7—7 when administered at increasing dose level and control.

(b) Kaplan Meier survival curves for capecitabine at escalating doses when administered at the 7—7 dosing schedule.